Literature DB >> 2294625

Results of a national survey of characteristics of hospital tumor conferences.

D E Henson1, R W Frelick, L G Ford, C R Smart, D Winchester, C Mettlin, J W Yates.   

Abstract

A descriptive survey of hospital tumor conferences, which are also referred to as tumor boards, was conducted by the National Cancer Institute in collaboration with the American College of Surgeons and Roswell Park Memorial Institute. The survey was done to assess the involvement of the tumor conference in the care of the patient with cancer and to lay the groundwork for additional studies of the conference. The data from the descriptive survey are based on questionnaires sent to 1,700 hospitals in the United States. The questionnaires requested information about frequency, attendance, composition, role of the chairman, agenda and other variables that relate to the format and purpose of the conference. From the results, we conclude that tumor conferences are an accepted and established institution for the multidisciplinary care of patients with cancer. They are a major source of consultation and education for physicians and for other professionals involved in oncology. Tumor conferences are conducted in a wide spectrum of hospitals and related institutions that vary in size and function.

Entities:  

Mesh:

Year:  1990        PMID: 2294625

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  8 in total

1.  Physician and Practice Characteristics Influencing Tumor Board Attendance: Results From the Provider Survey of the Los Angeles Women's Health Study.

Authors:  Kevin S Scher; Diana M Tisnado; Danielle E Rose; John Lloyd Adams; Clifford Y Ko; Jennifer L Malin; Patricia A Ganz; Katherine L Kahn
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

2.  Tumor board participation among physicians caring for patients with lung or colorectal cancer.

Authors:  Kenneth L Kehl; Mary Beth Landrum; Katherine L Kahn; Stacy W Gray; Aileen B Chen; Nancy L Keating
Journal:  J Oncol Pract       Date:  2015-04-28       Impact factor: 3.840

3.  Tumor boards and the quality of cancer care.

Authors:  Nancy L Keating; Mary Beth Landrum; Elizabeth B Lamont; Samuel R Bozeman; Lawrence N Shulman; Barbara J McNeil
Journal:  J Natl Cancer Inst       Date:  2012-12-28       Impact factor: 13.506

4.  Management of colorectal cancer with synchronous liver metastases: impact of multidisciplinary case conference review.

Authors:  Kerollos N Wanis; Karen Pineda-Solis; Mauro E Tun-Abraham; Jake Yeoman; Stephen Welch; Kelly Vogt; Julie Ann M Van Koughnett; Michael Ott; Roberto Hernandez-Alejandro
Journal:  Hepatobiliary Surg Nutr       Date:  2017-06       Impact factor: 7.293

5.  Tumor board: more than treatment planning--a 1-year prospective survey.

Authors:  Troy A Gatcliffe; Robert L Coleman
Journal:  J Cancer Educ       Date:  2008       Impact factor: 2.037

6.  Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program.

Authors:  Lindsay Kuroki; Ashley Stuckey; Priya Hirway; Christina A Raker; Christina A Bandera; Paul A DiSilvestro; Cornelius O Granai; Robert D Legare; Bachir J Sakr; Don S Dizon
Journal:  Gynecol Oncol       Date:  2009-12-29       Impact factor: 5.482

Review 7.  Benefits of multidisciplinary teamwork in the management of breast cancer.

Authors:  Cath Taylor; Amanda Shewbridge; Jenny Harris; James S Green
Journal:  Breast Cancer (Dove Med Press)       Date:  2013-08-30

8.  Digital Tumor Board Solutions Have Significant Impact on Case Preparation.

Authors:  Richard D Hammer; Donna Fowler; Lincoln R Sheets; Athanasios Siadimas; Chaohui Guo; Matthew S Prime
Journal:  JCO Clin Cancer Inform       Date:  2020-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.